A Trial of HS-10511 in Healthy Subjects

Summary

This study is a phase I, randomized, double-blind, placebo-controlled clinical trial evaluating the safety, tolerability, and pharmacodynamic (PK) and pharmacodynamic (PD) characteristics of HS-10511 when administered as single oral dose and multiple oral doses in healthy adult subjects.

Timeline

Start

2024-01-31

Primary completion

2024-06-30

Completion

2024-12-31

Drugs

Indications